Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Mario Negri Gynecologic Oncology"'
Autor:
Pignata, S, Scambia, G, Katsaros, D, Gallo, C, Pujade Lauraine, E, De Placido, S, Bologna, A, Weber, B, Raspagliesi, F, Panici, Pb, Cormio, G, Sorio, R, Cavazzini, Mg, Ferrandina, G, Breda, E, Murgia, V, Sacco, C, Cinieri, S, Salutari, V, Ricci, C, Pisano, C, Greggi, S, Lauria, R, Lorusso, D, Marchetti, C, Selvaggi, L, Signoriello, S, Piccirillo, Mc, DI MAIO, Massimo, Perrone, F, Multicentre Italian Trials in Ovarian cancer, Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens et du sein, Mario Negri Gynecologic Oncology, European Network of Gynaecological Oncological Trial Groups, Gynecologic Cancer InterGroup Investigators
Background: Carboplatin plus paclitaxel administered every 3 weeks is standard first-line chemotherapy for patients with advanced ovarian cancer. A weekly paclitaxel schedule combined with carboplatin every 3 weeks prolonged progression-free survival
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35e0b7d8280f4cac191f209083620cb9
http://hdl.handle.net/10807/72293
http://hdl.handle.net/10807/72293
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Harter P; Department of Gynaecology & Gynaecologic Oncology, Ev. Kliniken Essen-Mitte, Essen, Philipps University, Marburg, and Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Studiengruppe, Germany., Marth C; Department of Obstetrics and Gynecology, Medical University Innsbruck, Innsbruck, and Arbeitsgemeinschaft Gynäkologische Onkologie (AGO-Austria), Austria., Mouret-Reynier MA; Department of Medical Oncology, Centre Jean Perrin, Clermont Ferrand, and Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), France., Cropet C; Department of Biostatistics, Centre Léon Bérard, Lyon, France., Lorusso D; Istituto Tumori Milano + Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Catholic University of Sacred Heart, Milan, and Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies (MITO), Italy., Guerra-Alía EM; Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, and Grupo Español de Investigación en Cáncer de Ovario (GEICO), Spain., Matsumoto T; Ehime University Hospital, Toon, and Gynecologic Oncology Trial and Investigation Consortium (GOTIC), Japan., Vergote I; Department of Obstetrics and Gynaecology, University Hospital Leuven, Leuven Cancer Institute, Leuven, and Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Belgium, European Union., Colombo N; University of Milan-Bicocca, European Institute of Oncology IRCCS, Milan, and Mario Negri Gynecologic Oncology Group (MANGO), Italy., Mäenpää J; Department of Obstetrics and Gynecology and Cancer Center, Tampere University Hospital, Tampere, and Nordic Society of Gynecologic Oncology (NSGO), Finland., Lebreton C; Department of Medical Oncology, Institut Bergonié, Bordeaux, and GINECO, France., de Gregorio N; Universitätsklinikum Ulm, Klinik für Frauenheilkunde und Geburtshilfe, Ulm, SLK-Kliniken Heilbronn GmbH, Frauenklinik, Heilbronn, and AGO Studiengruppe, Germany., Mosconi AM; S.C. di Oncologia Medica Osp. S. Maria della Misericordia - AO di Perugia, Perugia, and MITO, Italy., Rubio-Pérez MJ; Medical Oncology Department, Hospital Reina Sofía, Córdoba, and GEICO, Spain., Bourgeois H; Medical Oncology Department, Centre Jean Bernard - Clinique Victor Hugo, Le Mans, and GINECO, France., Fasching PA; Gynecology and Obstetrics Translational Medicine, Universitätsfrauenklinik Erlangen, Erlangen, and AGO Studiengruppe, Germany., Cecere SC; Department of Urology and Gynecology, Istituto Nazionale Tumori 'Fondazione G Pascale', IRCCS, Naples, and MITO, Italy., Hardy-Bessard AC; Oncologie Médicale, Centre CARIO - HPCA, Plérin Sur Mer, Plérin, and GINECO, France., Denschlag D; Hochtaunuskliniken, Bad Homburg, and AGO Studiengruppe, Germany., de Percin S; APHP - Hôpital Cochin, Paris, and GINECO, France., Hanker L; Universitätsklinikum Schleswig-Holstein, Klinik für Gynäkologie und Geburtshilfe, Campus Lübeck, Lübeck and Universitätsklinikum Münster, Klinik für Gynäkologie und Geburtshilfe, Münster and AGO Studiengruppe, Germany., Favier L; Centre Georges François Leclerc, Dijon, and GINECO, France., Bauerschlag D; Universitätsklinikum Schleswig-Holstein, Klinik für Gynäkologie und Geburtshilfe, Campus Kiel, Kiel, and AGO Studiengruppe, Germany., Desauw C; Centre Hospitalier Régional Universitaire de Lille, Lille, and GINECO, France., Hillemanns P; Medizinische Hochschule Hannover, Klinik für Frauenheilkunde und Geburtshilfe, Hannover, and AGO Studiengruppe, Germany., Largillier R; Centre Azuréen de Cancérologie, Mougins, and GINECO, France., Sehouli J; Charité - Campus-Virchow-Klinikum, Department of Gynecology with Center of Oncological Surgery Berlin, Frauenklinik, Berlin, and AGO Studiengruppe, Germany., Grenier J; Institut du cancer Avignon-Provence, Avignon, and GINECO, France., Pujade-Lauraine E; Association de Recherche Cancers Gynécologiques (ARCAGY) Research, Paris, and GINECO, France., Ray-Coquard I; Department of Medical Oncology, Centre Léon Berard, Lyon, and GINECO, France. Electronic address: isabelle.ray-coquard@lyon.unicancer.fr.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Nov 09. Date of Electronic Publication: 2024 Nov 09.
Autor:
Van Gorp T; Division of Gynaecological Oncology, University Hospital Leuven, Leuven Cancer Institute, Leuven, Belgium; Belgian and Luxembourg Gynaecological Oncology Group (BGOG), Leuven, Belgium. Electronic address: toon.vangorp@uzleuven.be., Cibula D; Department of Gynecology, Obstetrics and Neonatology, General University Hospital in Prague, First Faculty of Medicine, Charles University, Prague, Czech Republic; Central and Eastern European Gynecologic Oncology Group (CEEGOG), Prague, Czech Republic., Lv W; Department of Gynecologic Oncology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China., Backes F; Division of Gynecologic Oncology, Ohio State University and James Cancer Hospital, Columbus, USA; GOG Foundation, Philadelphia, USA., Ortaç F; Ankara University School of Medicine, Ankara, Turkey; Turkish Society of Gynecologic Oncology (TRSGO), Istanbul, Turkey., Hasegawa K; Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Hidaka, Saitama Prefecture, Japan., Lindemann K; Department of Gynecological Oncology, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Nordic Society of Gynaecological Oncology - Clinical Trial Unit (NSGO-CTU), Copenhagen, Denmark., Savarese A; IRCCS - Regina Elena National Cancer Institute, Rome, Italy; Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies (MITO), Rome, Italy., Laenen A; Belgian and Luxembourg Gynaecological Oncology Group (BGOG), Leuven, Belgium; Leuven Biostatistics and Statistical Bioinformatics Center, KU Leuven, Leuven, Belgium., Kim YM; Department of Obstetrics and Gynecology, Asan Medical Center, University of Ulsan, Seoul, Republic of Korea., Bodnar L; Department of Clinical Oncology and Radiotherapy, Mazovia Regional Hospital, Siedlce Oncology Center, Siedlce, Poland; Polish Group of Gynaecological Oncology (PGOG), Warsaw, Poland., Barretina-Ginesta MP; Catalan Institute of Oncology and Girona Biomedical Research Institute, Medical School University of Girona, Girona, Spain; Spanish Ovarian Cancer Research Group (GEICO), Madrid, Spain., Gilbert L; Division of Gynecologic Oncology, McGill University Health Centre, Montreal, Canada; Women's Health Research Unit, Research Institute McGill University Health Centre, Montreal, Canada; Gerald Bronfman Department of Oncology, McGill University Health Centre, Montreal, Canada., Pothuri B; GOG Foundation, Philadelphia, USA; Department of Obstetrics and Gynecology and Medicine, Division of Gynecologic Oncology, Perlmutter Cancer Center, NYU Langone Health, New York, USA., Chen X; Department of Oncology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China; Shanghai Gynecologic Oncology Group (SGOG), Shanghai, China., Flores MB; Instituto Oncológico Fundación Arturo López Pérez, Santiago, Chile., Levy T; Gynecologic Oncology Unit, Department of Obstetrics and Gynecology, Israeli Society of Gynecology Oncology (ISGO), Wolfson Medical Center, Affiliated with the Faculty of Medical and Health Sciences, Tel Aviv University, Holon, Israel., Colombo N; Gynecologic Oncology Program, European Institute of Oncology IRCCS, Milan, Italy; Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy; Mario Negri Gynecologic Oncology (MaNGO), Milan, Italy., Papadimitriou C; Aretaieio University Hospital, National and Kapodistrian University of Athens, Athens, Greece; Hellenic Cooperative Oncology Group (HeCOG), Athens, Greece., Buchanan T; GOG Foundation, Philadelphia, USA; Jefferson Health, Asplundh Cancer Pavilion, Willow Grove, USA., Hanker LC; University Hospital Schleswig-Holstein, Lubeck, Germany; Department of Gynecology and Obstetrics, University Hospital Muenster, Muenster, Germany; German Gynecological Oncology Group (AGO), Wiesbaden, Germany., Eminowicz G; University College London Hospitals and University College London, London, UK; National Cancer Research Institute (NCRI), London, UK., Rob L; Central and Eastern European Gynecologic Oncology Group (CEEGOG), Prague, Czech Republic; Department of Obstetrics and Gynecology, Faculty Hospital Kralovske Vinohrady, 3rd Faculty of Medicine, Charles University, Prague, Czech Republic., Black D; GOG Foundation, Philadelphia, USA; Department of Obstetrics and Gynecology, LSU Health Shreveport, Shreveport, USA; Willis-Knighton Physician Network, Shreveport, USA., Lichfield J; MSD, London, UK., Lin G; Merck & Co., Inc., Rahway, USA., Orlowski R; Merck & Co., Inc., Rahway, USA., Keefe S; Merck & Co., Inc., Rahway, USA., Lortholary A; Centre Catherine de Sienne, Hôpital Privé du Confluent, Nantes, France; National Investigators Group for the Study of Ovarian and Breast Cancers (GINECO), Paris, France., Slomovitz B; GOG Foundation, Philadelphia, USA; Mount Sinai Medical Center, Miami Beach, USA.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Nov; Vol. 35 (11), pp. 968-980. Date of Electronic Publication: 2024 Sep 14.
Autor:
Slomovitz BM; Mount Sinai Medical Center, Miami Beach, FL.; GOG Foundation, Philadelphia, PA., Cibula D; Department of Gynecology, Obstetrics and Neonatology, General University Hospital in Prague, First Faculty of Medicine, Charles University, Prague, Czech Republic.; Central and Eastern European Gynecologic Oncology Group (CEEGOG), Prague, Czech Republic., Lv W; Department of Gynecologic Oncology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China., Ortaç F; Ankara University School of Medicine, Ankara, Turkey.; Turkish Society of Gynecologic Oncology (TRSGO), Istanbul, Turkey., Hietanen S; Turku University Hospital, FICAN West Cancer Centre, Turku, Finland.; Nordic Society of Gynaecological Oncology (NSGO), Copenhagen, Denmark., Backes F; GOG Foundation, Philadelphia, PA.; Division of Gynecologic Oncology, Ohio State University and James Cancer Hospital, Columbus, OH., Kikuchi A; Department of Gynecology, Niigata Cancer Center Hospital, Niigata, Japan., Lorusso D; Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome and Humanitas University, Rozzano (Milan), Italy.; Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies (MITO), Rome, Italy., Dańska-Bidzińska A; Department of Gynecological Oncology, 2nd Division of Obstetrics and Gynecology, Medical University of Warsaw, Warsaw, Poland.; Polish Group of Gynaecological Oncology (PGOG), Warsaw, Poland., Samouëlian V; Gynecologic Oncology, Centre Hospitalier de l'Université de Montréal (CHUM), Centre de Recherche du CHUM (CRCHUM), Université de Montréal, Montreal, QC, Canada., Barretina-Ginesta MP; Catalan Institute of Oncology and Girona Biomedical Research Institute, Medical School University of Girona, Girona, Spain.; Spanish Ovarian Cancer Research Group (GEICO), Madrid, Spain., Vulsteke C; Integrated Cancer Center Ghent, Department of Medical Oncology, AZ Maria Middelares Ghent and Center of Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Wilrijk, Antwerp, Belgium.; Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Leuven, Belgium., Lai CH; Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Linkou Branch, Chang Gung University, College of Medicine, Taoyuan, Taiwan.; Gynecologic Cancer Research Center, Chang Gung Memorial Hospital, Linkou Branch, Taiwan.; Taiwanese Gynecologic Oncology Group (TGOG), Zhunan, Taiwan., Pothuri B; GOG Foundation, Philadelphia, PA.; Department of Obstetrics and Gynecology and Medicine, Division of Gynecologic Oncology, Perlmutter Cancer Center, NYU Langone Health, New York, NY., Zhang Y; Department of Gynecology, Xiangya Hospital, Central South University, Changsha, Hunan, PR China., Magallanes-Maciel M; Centro Oncologico Internacional, Mexico City, Mexico., Amit A; Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.; Department of Obstetrics and Gynecology, Rambam Health Care Campus, Haifa, Israel.; Israeli Society of Gynecology Oncology (ISGO), Israel., Guarneri V; Department of Surgery, Oncology and Gastroenterology (DISCOG), University of Padova, Padova, Italy.; Medical Oncology 2, Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy.; Mario Negri Gynecologic Oncology (MaNGO), Milan, Italy., Zagouri F; Department of Clinical Therapeutics, Medical School of National and Kapodistrian University of Athens, 'Alexandra' General Hospital of Athens, Athens, Greece.; Hellenic Cooperative Oncology Group (HeCOG), Athens, Greece., Bell M; GOG Foundation, Philadelphia, PA.; Sanford Health, Sioux Falls, SD., Welz J; Department of Gynecology and Gynecologic Oncology, Evang. Kliniken Essen-Mitte, Essen, Germany.; German Gynecological Oncology Group (AGO), Essen, Germany., Eminowicz G; University College London Hospitals and University College London, London, United Kingdom.; National Cancer Research Institute (NCRI), London, United Kingdom., Hruda M; Central and Eastern European Gynecologic Oncology Group (CEEGOG), Prague, Czech Republic.; Department of Gynecology and Obstetrics, University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Prague, Czech Republic., Willmott LJ; GOG Foundation, Philadelphia, PA.; The University of Arizona College of Medicine, Phoenix, AZ.; Creighton University School of Medicine at Dignity Health St Joseph's Hospital and Medical Center, Phoenix, AZ.; Maricopa Integrated Health System, Phoenix, AZ.; Arizona Center for Cancer Care (Virginia Piper Cancer Care Network), Phoenix, AZ., Lichfield J; MSD UK, London, United Kingdom., Wang W; MSD China, Beijing, China., Orlowski R; Merck & Co, Inc, Rahway, NJ., Aktan G; Merck & Co, Inc, Rahway, NJ., Gladieff L; Medical Oncology, Oncopole CLAUDIUS REGAUD, IUCT-Oncopole, Toulouse, France.; National Investigators Group for the Study of Ovarian and Breast Cancers (GINECO), Paris, France., Van Gorp T; Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Leuven, Belgium.; Division of Gynaecological Oncology, University Hospital Leuven, Leuven Cancer Institute, Leuven, Belgium.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Oct 16, pp. JCO2401887. Date of Electronic Publication: 2024 Oct 16.
Autor:
González-Martín A; Medical Oncology Department, Translational Oncology Group, CIMA, Universidad de Navarra, Cancer Center Clínica Universidad de Navarra, Madrid, Spain.; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain., Rubio MJ; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Medical Oncology Department, Reina Sofia University Hospital of Cordoba, Cordoba, Spain., Heitz F; Department for Gynaecology and Gynaecologic Oncology, Kliniken Essen-Mitte, Essen, Germany.; Department of Gynaecology, Berlin Institute of Health, Charité-Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Arbeitsgemeinschaft Gynaekologische Onkologie (AGO), Wiesbaden, Germany., Depont Christensen R; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain., Colombo N; Gynecologic Oncology Program, European Institute of Oncology, IRCCS, Milan, Italy.; Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy.; Mario Negri Gynecologic Oncology Group (MaNGO), Milan, Italy., Van Gorp T; Division of Gynaecological Oncology, University Hospital Leuven, Leuven Cancer Institute, Leuven, Belgium.; Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Leuven, Belgium., Romeo M; Medical Oncology Department, Institut Català d'Oncologia, Institut Germans Trias i Pujol (IGTP), Badalona, Spain.; Centre Leon Bérard and University of Lyon, Lyon, France., Ray-Coquard I; Centre Leon Bérard and University of Lyon, Lyon, France.; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Paris, France., Gaba L; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Medical Oncology Department Hospital Clinic and Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain., Leary A; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Paris, France.; Gustave Roussy, Villejuif, France., De Sande LM; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Medical Oncology Service, Complejo Asistencial Universitario de León, León, Spain., Lebreton C; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Paris, France.; Medical Oncology Department-Gynecologic Group, Institut Bergonié-Centre Régional de Lutte Contre le Cancer (CLCC), Bordeaux, France., Redondo A; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Medical Oncology Department, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain., Fabbro M; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Paris, France.; Institut du Cancer de Montpellier Val d'Aurelle, Montpellier, France., Barretina Ginesta MP; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Medical Oncology Department, Institut Català d'Oncologia, IDIBGI, Girona, Spain., Follana P; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Paris, France.; Centre Antoine Lacassagne, Nice, France., Pérez-Fidalgo JA; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Medical Oncology Department, University Hospital of Valencia, INCLIVA Biomedical Research Institute, CIBERONC, Valencia, Spain., Rodrigues M; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Paris, France.; Institut Curie, Paris, France., Santaballa A; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Hospital Universitario La Fe, Valencia, Spain., Sabatier R; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Paris, France.; Institut Paoli Calmettes, Marseille, France., Bermejo-Pérez MJ; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, Málaga, Spain., Lotz JP; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Paris, France.; Hôpital Tenon, Assistance Publique Hôpitaux de Paris, Sorbonne Université, Paris, France., Pardo B; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Institut Català d'Oncologia, Hospital Duran i Reynals, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain., Marquina G; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Department of Medical Oncology, Department of Medicine, Hospital Clínico San Carlos, School of Medicine, Instituto de Investigación Sanitaria (IdISSC), EURACAN Referral Centre, Universidad Complotense de Madrid (UCM), Madrid, Spain., Sánchez-Lorenzo L; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Clínica Universidad de Navarra, Madrid, Spain., Quindós M; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; A Coruña Biomedical Research Institute (INIBIC), A Coruña University Hospital, A Coruña, Spain., Estévez-García P; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Hospital Universitario Virgen del Rocío and Instituto de Biomedicina de Sevilla (IBIS), Seville, Spain., Guerra Alía E; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Hospital Universitario Ramón y Cajal, Madrid, Spain., Manso L; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Hospital Universitario 12 de Octubre, Madrid, Spain., Casado V; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Hospital Universitario Fundación Jimenez Díaz, Madrid, Spain., Kommoss S; Arbeitsgemeinschaft Gynaekologische Onkologie (AGO), Wiesbaden, Germany.; Universitätsklinikum Tübingen, Universitätsfrauenklinik, Tübingen, Germany.; Current address: Diakonie-Klinikum Schwäbisch Hall gGmbH, Schwäbisch Hall, Germany., Tognon G; Mario Negri Gynecologic Oncology Group (MaNGO), Milan, Italy.; Spedali Civili di Brescia, Brescia, Italy., Henry S; Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Leuven, Belgium.; CHU UCL NAMUR (site Ste Elisabeth), Université Catholique de Louvain, Namur, Belgium., Bruchim I; Gynecologic Oncology Department, Hillel Yaffe Medical Center, Affiliated with the Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.; Israeli Society of Gynecologic Oncology (ISGO), Ashkelon, Israel., Oaknin A; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Medical Oncology Service, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Selle F; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Paris, France.; Medical Oncology Service, Groupe Hospitalier Diaconesses Croix Saint Simon, Paris, France.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Sep 18, pp. JCO2400668. Date of Electronic Publication: 2024 Sep 18.
Autor:
Lorusso D; Istituto Tumori Milano + Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy kettalorusso@libero.it.; Catholic University of Sacred Heart, Milan, Italy.; Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies, (MITO), Italy., Mouret-Reynier MA; Department of Medical Oncology, Centre Jean Perrin, Clermont Ferrand, France.; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, (GINECO), France., Harter P; Department of Gynaecology & Gynaecologic Oncology, Ev. Kliniken Essen-Mitte, Essen, Germany.; Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe, (AGO), Germany., Cropet C; Department of Biostatistics, Centre Léon Bérard, Lyon, France., Caballero C; Servicio de Oncología Médica, Hospital General Universitario de Valencia, Valencia, Spain.; Grupo Español de Investigación en Cáncer de Ovario, (GEICO), Spain., Wolfrum-Ristau P; Department of Obstetrics and Gynecology, Paracelsus Medical University Salzburg, Salzburg, Austria.; Arbeitsgemeinschaft Gynaekologische Onkologie Study Group, (AGO-Austria), Austria., Satoh T; Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.; Gynecologic Oncology Trial and Investigation Consortium, (GOTIC), Japan., Vergote I; Department of Obstetrics and Gynaecology, University Hospital Leuven, Leuven Cancer Institute, Leuven, Belgium, European Union.; Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Belgium, European Union., Parma G; Gynecologic Oncology Program, European Institute of Oncology IRCCS, Milan, Italy.; Mario Negri Gynecologic Oncology Group, (MANGO), Italy., Nøttrup TJ; Department of Oncology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.; Nordic Society of Gynecologic Oncology, (NSGO), Denmark., Lebreton C; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, (GINECO), France.; Department of Medical Oncology, Institut Bergonié, Bordeaux, France., Fasching PA; Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe, (AGO), Germany.; Gynecology and Obstetrics Translational Medicine, Universitätsfrauenklinik Erlangen, Erlangen, Germany., Pisano C; Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies, (MITO), Italy.; Department of Urology and Gynecology, Istituto Nazionale Tumori, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)-Fondazione G. Pascale Napoli, Naples, Italy., Manso L; Grupo Español de Investigación en Cáncer de Ovario, (GEICO), Spain.; Department of Medical Oncology, Hospital 12 de Octubre, Madrid, Spain., Bourgeois H; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, (GINECO), France.; Medical Oncology Department, Centre Jean Bernard - Clinique Victor Hugo, Le Mans, France., Runnebaum I; Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe, (AGO), Germany.; Department of Gynecology and Reproductive Medicine, Jena University Hospital, Friedrich Schiller University, Jena, Germany., Zamagni C; Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies, (MITO), Italy.; IRCCS Azienda Ospedaliero-universitaria di Bologna, Bologna, Italy., Hardy-Bessard AC; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, (GINECO), France.; Oncologie Médicale, Centre CARIO - HPCA, Plérin Sur Mer, Plérin, France., Schnelzer A; Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe, (AGO), Germany.; Frauenklinik und Poliklinik Klinikum rechts der Isar, Technische Universität München, Munich, Germany., Fabbro M; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, (GINECO), France.; Institut du Cancer de Montpellier, Montpellier, France., Schmalfeldt B; Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe, (AGO), Germany.; Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany., Berton D; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, (GINECO), France.; L'Institut de Cancérologie de l'Ouest (ICO), Centre René Gauducheau, Saint Herblain, France., Belau A; Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe, (AGO), Germany.; Universitätsmedizin Greifswald, Frauenklinik & Frauenarztpraxis, Greifswald, Germany., Lotz JP; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, (GINECO), France.; Hôpital Tenon, APHP, Paris, France., Gropp-Meier M; Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe, (AGO), Germany.; Onkologie Ravensburg, Ravensburg, Germany., Gladieff L; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, (GINECO), France.; Oncopole CLAUDIUS REGAUD IUCT-Oncopole, Toulouse, France., Lück HJ; Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe, (AGO), Germany.; Gynäkologisch-Onkologische Praxis, Hannover, Germany., Abadie-Lacourtoisie S; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, (GINECO), France.; ICO Paul Papin, Angers, France., Pujade-Lauraine E; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, (GINECO), France.; Medical Oncology Department, ARCAGY Research, Paris, France., Ray-Coquard I; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, (GINECO), France.; Department of Medical Oncology, Centre Léon Berard, Lyon, France.
Publikováno v:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2024 Apr 01; Vol. 34 (4), pp. 550-558. Date of Electronic Publication: 2024 Apr 01.
Autor:
Pujade-Lauraine E; Association de Recherche Cancers Gynécologiques (ARCAGY)-Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Paris; GINECO, Paris. Electronic address: epujade@arcagy.org., Selle F; GINECO, Paris; Department of Medical Oncology, Groupe Hospitalier Diaconesses Croix Saint-Simon, Paris, France., Scambia G; Fondazione Policlinico Universitario A. Gemelli, IRCCS, Università Cattolica, Rome; Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies (MITO), Milan, Italy., Asselain B; Association de Recherche Cancers Gynécologiques (ARCAGY)-Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Paris; GINECO, Paris., Marmé F; University Hospital Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Studiengruppe, Essen, Germany., Lindemann K; Department of Gynaecological Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo; Nordic Society of Gynecologic Oncology (NSGO), Oslo, Norway., Colombo N; University of Milan-Bicocca and IEO European Institute of Oncology IRCCS, Milan; Mario Negri Gynecologic Oncology Group (MANGO), Italy., Mądry R; Uniwersytet Medyczny im.K.Marcinkowskiego w Poznaniu, Poznań; Polish Gynecologic Oncology Group (PGOG), Poznan, Poland., Glasspool R; Beatson West of Scotland Cancer Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow; National Cancer Research Institute (NCRI), London; Scottish Gynaecological Cancer Trials Group (SGCTG), Edinburgh, UK., Vergote I; University Hospitals Leuven, Leuven Cancer Institute, Leuven; Belgian and Luxembourg Gynaecological Oncology Group (BGOG), Leuven, Belgium., Korach J; Sheba Medical Center, Tel Aviv University, Tel Hashomer, Ramat Gan; Israeli Society of Gynecologic Oncology (ISGO), Tel Aviv, Israel., Lheureux S; Princess Margaret Hospital, Department of Medical Oncology, Toronto; Princess Margaret Consortium, Toronto, Canada., Dubot C; GINECO, Paris; Oncologie Médicale, Institut Curie Saint Cloud, Paris, France., Oaknin A; Gynaecologic Cancer Programme, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona; Grupo Español de Investigación en Cáncer de Ovario (GEICO), Madrid, Spain., Zamagni C; Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies (MITO), Milan, Italy; IRCCS Azienda Ospedaliero-universitaria di Bologna, Bologna, Italy., Heitz F; Department of Gynecology & Gynecologic Oncology, Ev. Kliniken Essen-Mitte, Essen; Department for Gynecology with the Center for Oncologic Surgery Charité Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin; Berlin Institute of Health, Berlin; AGO Studiengruppe, Wiesbaden, Germany., Gladieff L; GINECO, Paris; Institut Claudius Regaud IUCT-Oncopole, Toulouse, France., Rubio-Pérez MJ; Grupo Español de Investigación en Cáncer de Ovario (GEICO), Madrid, Spain; Reina Sofia University Hospital, Cordoba, Spain., Scollo P; Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies (MITO), Milan, Italy; Kore University Enna, Enna; Dipartimento di Ginecologia e Ostetricia, Ospedale Cannizzaro, Catania, Italy., Blakeley C; AstraZeneca, Cambridge, UK., Shaw B; AstraZeneca, Cambridge, UK., Ray-Coquard I; GINECO, Paris; Medical Oncology Department, Centre Léon Bérard and University Claude Bernard Lyon, Lyon, France., Redondo A; Grupo Español de Investigación en Cáncer de Ovario (GEICO), Madrid, Spain; La Paz University Hospital-IdiPAZ, Madrid, Spain.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2023 Dec; Vol. 34 (12), pp. 1152-1164. Date of Electronic Publication: 2023 Oct 04.
Autor:
Vergote I; Belgium and Luxembourg Gynaecological Oncology Group (BGOG) and University Hospitals Leuven, Division of Gynaecological Oncology, Leuven, European Union, Belgium. Electronic address: Ignace.vergote@uzleuven.be., Van Nieuwenhuysen E; Belgium and Luxembourg Gynaecological Oncology Group (BGOG) and University Hospitals Leuven, Division of Gynaecological Oncology, Leuven, European Union, Belgium., Casado A; Hospital Clínico San Carlos, Spain and Grupo Español de Cáncer de Ovario (GEICO), Madrid, Spain., Laenen A; Leuven Biostatistics and Statistical Bioinformatics Centre, KU Leuven, Leuven, Belgium., Lorusso D; Multicentre Italian Trials in Ovarian Cancer and Gynecologic malignancies (MITO) and Fondazione Policlinico Universitario Gemelli IRCCS and Catholic University of Sacred Heart, Roma, Italy., Braicu EI; Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie e.V (NOGGO) and Department of Gynecology with Center for Oncological Surgery, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Virchow Campus Clinic, Charité Medical University, Berlin, Germany; Stanford University, Department of Obstetrics and Gynecology, CA, USA., Guerra-Alia E; Hospital Universitario Ramón y Cajal, and GEICO, Madrid, Spain., Zola P; Mario Negri Gynecologic Oncology Group (MaNGO) and Department of Surgical Sciences Università degli Studi di Torino, Italy., Wimberger P; NOGGO and Technische Universität Dresden and NCT Dresden, Dresden, Germany., Debruyne PR; BGOG and Kortrijk Cancer Centre, AZ Groeninge, Kortrijk, Belgium; School of Life Sciences, Anglia Ruskin University, Cambridge, UK; School of Nursing & Midwifery, University of Plymouth, Plymouth, UK., Falcó E; GEICO and Policlinica Miramar, Palma de Mallorca, Spain., Ferrero A; MaNGO and Mauriziano Hospital and University of Torino, Torino, Italy., Muallem MZ; Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie e.V (NOGGO) and Department of Gynecology with Center for Oncological Surgery, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Virchow Campus Clinic, Charité Medical University, Berlin, Germany., Kerger J; BGOG and Instituut Jules Bordet, Brussels, Belgium., García-Martinez E; Hospital General Universitario Morales Meseguer, Murcia, Spain and GEICO., Pignata S; MITO and Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale Napoli, Italy., Sehouli J; Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie e.V (NOGGO) and Department of Gynecology with Center for Oncological Surgery, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Virchow Campus Clinic, Charité Medical University, Berlin, Germany., Van Gorp T; Belgium and Luxembourg Gynaecological Oncology Group (BGOG) and University Hospitals Leuven, Division of Gynaecological Oncology, Leuven, European Union, Belgium., Gennigens C; BGOG and CHU de Liège, Liège, Belgium., Rubio MJ; Hospital Reina Sofía, Córdoba, Spain and GEICO.
Publikováno v:
Gynecologic oncology [Gynecol Oncol] 2023 Jul; Vol. 174, pp. 80-88. Date of Electronic Publication: 2023 May 09.